Press/Media: Newspaper Article
| Title | Sixty seconds on . . . nasal vaccines |
|---|---|
| Degree of recognition | International |
| Media type | Web |
| Country/Territory | United Kingdom |
| Date | 6/05/22 |
| Description | Sinus up! Researchers at Lancaster University have developed one such nasal spray candidate, based on a poultry virus, and are now beginning human trials. During the preclinical phase, they reported that the spray “significantly reduced lung pathology, inflammation, and clinical disease” in rodents. Virologist Muhammad Munir said, “Our studies demonstrate that induction of a local immune response at the point of entry of SARS-CoV-2 has the potential not only to limit clinical disease but also—and perhaps even more importantly—virus transmission from infected to uninfected people.”1 |
| Persons | Muhammad Munir |